Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

NCT00790816 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms, Breast

Interventions

DRUG: Lapatinib in combination with an anti-cancer agent
DRUG: Lapatinib
DRUG: Lapatinib in combination with an anti-cancer agent as specified by parent protocol

Sponsor

Novartis Pharmaceuticals